Condition: Prosthetic-joint Infection · Sponsor: Peptilogics
The goal of this clinical trial is to evaluate whether the investigational drug PLG0206 can help reduce recurrence of infection in adults who have undergone total knee replacement and are receiving a DAIR (Debridement, Antibiotics, and Implant Retention) surgical procedure to treat a Prosthetic Joint Infection (PJI). The study will also assess the safety of PLG0206 when used as an irrigation solution during the DAIR procedure. Participants will receive either PLG0206 or a placebo (an inactive substance that looks like the investigational drug), in addition to standard of care treatments. All participants will be monitored for approximately one year following their DAIR procedure.
This description comes directly from the study's public registry record.
Peptilogics RETAIN Study Lead · 412-643-4924 · ClinicalTrials@peptilogics.com
Always discuss trial participation with your own doctor first.
| Clinical Trial Site | Sarasota, Florida, United States | Recruiting |
| Clinical Trial Site | Tamarac, Florida, United States | Recruiting |
| Clinical Trial Site | Baltimore, Maryland, United States | Recruiting |
| Clinical Trial Site | Boston, Massachusetts, United States | Recruiting |
| Clinical Trial Site | New York, New York, United States | Recruiting |
| Clinical Trial Site | Leland, North Carolina, United States | Recruiting |
| Clinical Trial Site | Cincinnati, Ohio, United States | Recruiting |
| Clinical Trial Site | Cleveland, Ohio, United States | Recruiting |
| Clinical Trial Site | Columbus, Ohio, United States | Recruiting |
| Clinical Trial Site | Pittsburgh, Pennsylvania, United States | Recruiting |
| Clinical Trial Site | Dallas, Texas, United States | Recruiting |
| Clinical Trial Site | Edinburg, Texas, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07214311